Comparison of heparin plus IIb/IIIa inhibition versus bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial

被引：0
|
作者：
Stone, Gregg W.
White, Harvey D.
Ohman, E. M.
Bertrand, Michel E.
Lincoff, A. M.
McLaurin, Brent T.
Cox, David A.
Pocock, Stuart J.
Ware, James H.
Colombo, Antonio
Mehran, Roxana
Moses, Jeffrey W.
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
[2] Cardiovasc Res Fdn, New York, NY USA
[3] Auckland City Hosp, Auckland, New Zealand
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Hop Cardiol, F-59037 Lille, France
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] AnMed Hlth, Anderson, SC USA
[8] Methodist Hosp, Indianapolis, IN USA
[9] London Sch Hyg & Trop Med, London WC1, England
[10] Harvard Univ, Boston, MA 02115 USA
[11] NYU, Sch Med, New York, NY USA
[12] Osped San Raphael, Milan, Italy
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [1] A comparison of heparin without glycoprotein IIb/IIIa inhibition versus bivalirudin in elective percutaneous coronary intervention
    Gade, Christopher L. F.
    Feldman, Dmitny N.
    Ross, Michael
    Polin, Nichole
    Bergman, Geoffrey
    Wong, S. Chiu
    Minutello, Robert M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B87 - B87
  • [2] Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)
    Kumar, Dinesh
    Dangas, George
    Mehran, Roxana
    Kirtane, Ajay
    Bertrand, Michel
    Ebrahimi, Ramin
    Guagliumi, Giulio
    Brar, Somjot
    Fahy, Martin
    Heller, Eric
    Moses, Jeffrey
    Stone, Gregg
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07): : 941 - 945
  • [3] Economic evaluation of bivalirudin with or without glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for early invasive management of acute coronary syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    York, Meghan
    Reynolds, Matthew R.
    McLaurin, Brent T.
    Cox, David A.
    Schneider, Elizabeth A.
    Shi, Chunxue
    Walczak, Joshua
    Vachon, David A.
    Berezin, Ronna H.
    Meman, Roxana
    Orman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A219 - A219
  • [4] Economic Evaluation of Bivalirudin With or Without Glycoprotein IIb/IIIa Inhibition Versus Heparin With Routine Glycoprotein IIb/IIIa Inhibition for Early Invasive Management of Acute Coronary Syndromes
    Pinto, Duane S.
    Stone, Gregg W.
    Shi, Chunxue
    Dunn, Elizabeth S.
    Reynolds, Matthew R.
    York, Meghan
    Walczak, Joshua
    Berezin, Ronna H.
    Mehran, Roxana
    McLaurin, Brent T.
    Cox, David A.
    Ohman, E. Magnus
    Lincoff, A. Michael
    Cohen, David J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (22) : 1758 - 1768
  • [5] Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors
    Abtahian, Farhad
    Waldo, Stephen
    Jang, Ik-Kyung
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (03) : 390 - 396
  • [6] Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
    Cohen, DJ
    Lincoff, AM
    Lavelle, TA
    Chen, HL
    Bakhai, A
    Berezin, RH
    Jackman, D
    Sarembock, IJ
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) : 1792 - 1800
  • [7] Glycoprotein IIb/IIIa inhibitors and bivalirudin in patients undergoing percutaneous coronary intervention
    Mahmoudi, M.
    Waksman, R.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (01): : 95 - 100
  • [8] Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial)
    Chew, DP
    Lincoff, AM
    Gurm, H
    Wolski, K
    Cohen, DJ
    Henry, T
    Feit, F
    Topol, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (05): : 581 - 585
  • [9] Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes
    Mak K.H.
    Moliterno D.J.
    [J]. Current Cardiology Reports, 1999, 1 (3) : 199 - 205
  • [10] Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Meta-Analysis of Randomized Controlled Trials
    Zhu, Jianbing
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C132 - C132
12345